Aortech International PLC
17 November 2005
For immediate release 17 November 2005
AorTech International plc
AGM Update
and Notice of Poll Meeting
AorTech International plc (AIM:AOR) today updates shareholders following its
Annual General Meeting on 26 October 2005.
At the AGM, all Resolutions were passed by a show of hands. However, in the
cases of resolution number 5 concerning the proposed election of Jon Peter
Pither as a Director and resolution number 7 concerning the proposed change of
name of the Company to AorTech Biomaterials plc, a poll was validly requested by
a person in attendance at the meeting. It has been determined that the poll
will be taken at 12 noon on Tuesday, 6 December 2005, at Buchanan
Communications, 107 Cheapside, London, EC2V 6DN. All shareholders entitled to
attend the Annual General Meeting will be entitled to attend the taking of the
poll.
Jon Pither was appointed as a Non-Executive Director on 1 March 2004 and took
over as Chairman on 13 May 2005. Jon has Board and City institutional
experience and also knowledge and experience of the challenges facing quoted
small cap companies with emerging technologies. The Board unanimously support
the election of Jon Pither to allow him to continue as Chairman.
The objective in proposing the change of the name from AorTech International plc
to AorTech Biomaterials plc is to reflect more accurately the future of the
Company's focus on the development and commercial applications of its
biomaterial products. The Company's subsidiary in Australia, where the research
and operational activity is now centred, is named AorTech Biomaterials Pty Ltd.
Given that the UK operation is administrative rather than marketing related, the
costs of such a change would be relatively minimal in terms of reprinting of
stationery and other related items.
Shareholders are being sent an explanatory letter early next week, together with
a proxy card, and are required to lodge the card in the Registrars' offices no
later than noon on Monday, 5 December 2005 in order for it to be valid. Proxies
that were lodged prior to the Annual General Meeting will remain valid unless
revoked by submitting the new proxy card. Copies of the letter to the
shareholders and the poll card will be made available to the public from the
date of the announcement for a period of one month, free of charge, and can be
obtained from the Company's office whose address is given below.
The poll will be taken at 12 noon on Tuesday, 6 December, 2005 at Buchanan
Communications and the results announced to the Stock Exchange as soon as
possible thereafter. Shareholders are entitled to attend. Return of the proxy
form does not prevent a member from attending the poll and voting in person.
For further information please contact:
AorTech International plc 0870 850 8286
David Parsons, Company Secretary
Buchanan Communications 020 7466 5000
Ben Willey, Lisa Baderoon, Rebecca Skye Dietrich
AorTech International plc
Prestige Travel Suite
Barclays Bank House
81-83 Victoria Road
Surbiton
Surrey
KT6 4NS
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.